Fatty liver disease packs a punch on wallets in flanders
NCT ID NCT05035043
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at the economic burden of non-alcoholic fatty liver disease (NAFLD) in 73 adults in Flanders, Belgium. Researchers measured healthcare costs, patient expenses, and quality of life using questionnaires. The goal was to understand the financial impact of the disease, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAFLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hasselt University
Hasselt, 3500, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could immune cells in fat hold the key to Obesity-Related disease?
- A new MRI technique could see inside the Liver's metabolism without a biopsy
- Could a common b vitamin tame fatty liver?
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- Can a sugar test reveal how fatty liver begins in obese adolescents?
- Can fatty liver in children lead to serious liver disease? a Long-Term study aims to find out